Rivera v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided August 12, 2025·No. 20-1908V·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 20-1908V Filed: July 18, 2025

Special Master Horner ALICE RIVERA,

Petitioner, v.

SECRETARY OF HEALTH AND HUMAN SERVICES,

Respondent.

Michael Adly Baseluos, Baseluos Law Firm, PLLC, San Antonio, TX, for petitioner. Mary Eileen Holmes, U.S. Department of Justice, Washington, DC, for respondent.

DECISION ON INTERIM ATTORNEYS’ FEES AND COSTS1

On December 21, 2020, petitioner filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. § 300aa-10, et seq. (2012) (“Vaccine Act”).2 (ECF No. 1.) Petitioner alleged that she suffered a shoulder injury related to vaccine administration (“SIRVA”), or alternatively a shoulder injury caused-in- fact by her vaccination, following her receipt of an influenza (“flu”) vaccine on October 26, 2019. (Id.) Based on the allegations of the petition, the case was initially assigned to the Chief Special Master for potential informal resolution as part of the Special Processing Unit (“SPU”). (ECF Nos. 19-20.) However, settlement discussions were unsuccessful, and the Chief Special Master reassigned the case to the undersigned on June 3, 2025, in light of petitioner’s request that she be permitted to file an expert report. (ECF Nos. 87-88.) 1 Because this document contains a reasoned explanation for the action taken in this case, it must be

made publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the document will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. 2 Within this decision, all citations to § 300aa will be to the relevant sections of the Vaccine Act at 42

U.S.C. § 300aa-10, et seq.

1 On February 20, 2024, while the case was still pending in the SPU, petitioner moved for an award of interim attorneys’ fees and costs totaling $37,883.25, including $36,642.00 in attorneys’ fees and $1,241.25 in attorneys’ costs. (ECF No. 61, p. 4.) Respondent filed his response on February 28, 2024. (ECF No. 62.) Respondent argued that an interim award of attorneys’ fees and costs was not appropriate given that the case remained in the SPU. (Id. at 2.) However, respondent deferred to the special master with respect to the statutory requirements for an award of attorneys’ fees and costs. (Id. at 3.) Additionally, respondent objected to certain billing and costs. (Id. at 4.) Petitioner did not file a reply.3

Section 15(e)(1) of the Vaccine Act allows for the special master to award “reasonable attorneys’ fees, and other costs.” § 300aa-15(e)(1)(A)-(B). Petitioners are entitled to an award of reasonable attorneys’ fees and costs if they are entitled to compensation under the Vaccine Act or, even if they are unsuccessful, if the special master finds that the petition was filed in good faith and with a reasonable basis. Avera v. Sec’y of Health & Human Servs., 515 F.3d 1343, 1352 (Fed. Cir. 2008). In this case, respondent does not dispute this petition had a reasonable basis, instead deferring to the special master on that point. (ECF No. 62, p. 3.) Moreover, the Chief Special Master observed in his prior finding of fact that, although a Table claim may be doubtful, “a non-Table claim is likely viable,” albeit requiring expert support that remains outstanding at this time. (ECF No. 79, p. 14.)

Additionally, the Federal Circuit has concluded that interim fee awards are permissible and appropriate under the Vaccine Act. Shaw v. Sec’y of Health & Human Servs., 609 F.3d 1372, 1374-75 (Fed. Cir. 2010); Avera, 515 F.3d at 1352. In Avera, the Federal Circuit stated, “[i]nterim fees are particularly appropriate in cases where proceedings are protracted and costly experts must be retained.” 515 F.3d at 1352. In Shaw, the Federal Circuit clarified that “where the claimant establishes that the cost of litigation has imposed an undue hardship and that there exists a good faith basis for the claim, it is proper for the special master to award interim attorneys’ fees.” 609 F.3d at 1375. Here, respondent’s objection was premised on the streamlined and expedited nature of SPU proceedings, but that argument was essentially mooted by the reassignment of the case to the undersigned for more thorough litigation. The amount at issue on this motion just barely meets the minimum threshold for attorneys’ fees that special masters have often used to assess when a hardship is likely indicated, though the costs fall well below what could be considered significant. E.g., Chinea v. Sec’y of Health & Human Servs., No. 15-95V, 2019 WL 3206829, at *2 (Fed. Cl. Spec. Mstr. June 11, 2019) (observing three factors that have been considered when exercising discretion to award interim attorneys’ fees: (1) whether the fee request exceeds $30,000; (2) whether the costs requested, in the aggregate, are more than $15,000; and 3 After this case was reassigned to the undersigned, petitioner’s counsel e-mailed my law clerk on June

16, 2025, copying respondent’s counsel, asking whether I would entertain the motion for interim fees and costs. He indicated that “I can file a response to Respondent’s objections if the Court is going to entertain my request for interim fees.” However, as the docket reflects, the deadline for petitioner’s filing of any reply was March 6, 2024. See also Vaccine Rule 20(b)(2) (“A reply to a response or an objection may be filed within 7 days after service of the response or objection.”)

2 (3) if the case has been pending for more than 18 months (citing Knorr v. Sec’y of Health & Human Servs., No. 15-1169V, 2017 WL 2461375 (Fed. Cl. Spec. Mstr. Apr. 17, 2017))). Given that counsel of record is a solo practitioner, and given the length of time this case has remained pending, I have concluded as a matter of discretion that an interim award is appropriate.4

It is “well within the special master’s discretion” to determine the reasonableness of fees. Saxton v. Sec’y of Health & Human Servs., 3 F.3d 1517, 1521-22 (Fed. Cir. 1993); see also Hines ex rel. Sevier v. Sec’y of Health & Human Servs., 22 Cl. Ct. 750, 753 (1991) (“[T]he reviewing court must grant the special master wide latitude in determining the reasonableness of both attorneys’ fees and costs.”). The Federal Circuit has approved the lodestar approach to determine reasonable attorneys’ fees and costs under the Vaccine Act. Avera, 515 F.3d at 1347-48. This is a two-step process. Id. First, a court determines an “initial estimate . . . by ‘multiplying the number of hours reasonably expended on the litigation times a reasonable hourly rate.’” Id. (quoting Blum v. Stenson, 465 U.S. 886, 888 (1984)).

Free access — add to your briefcase to read the full text and ask questions with AI

Rivera v. Secretary of Health and Human Services, (uscfc 2025).

Rivera v. Secretary of Health and Human Services (Rivera v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related